Autologous Muscle Derived Cells for Underactive Bladder

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

November 30, 2020

Conditions
Urinary RetentionUrinary Incontinence
Interventions
BIOLOGICAL

Autologous Muscle Derived Cells

A small sample of the subject's own thigh muscle is obtained by needle biopsy. The biopsy sample is sent to Cook Myosite, Inc. for growth and processing. When the sample cell dosage is achieved the cells are frozen and sent back to the treatment site. The cells are thawed, diluted and injected under lighted instrumentation and visualization into about 30 sites in the bladder wall.

Trial Locations (1)

48073

Beaumont Health, Royal Oak

All Listed Sponsors
lead

Jason Gilleran

OTHER

NCT02463448 - Autologous Muscle Derived Cells for Underactive Bladder | Biotech Hunter | Biotech Hunter